Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
5
×
life sciences
national blog main
texas blog main
5
×
texas top stories
biotech
boston blog main
detroit blog main
detroit top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
indiana blog main
indiana top stories
medical device
national
startups
abbvie
astrazeneca
cancer immunotherapy
clinical trials
covid-19
drug development
entrepreneurship
europe blog main
europe top stories
What
sciences
5
×
life
acquisitions
bio
biotechs
ceo
companies
daniel
gilead
ipo
new
o’day
roundup
week
years
action
admits
ago
announced
antonio
big
biggest
bringing
build
businesses
buy
city
classes
club
collabs
combinator
company’s
continued
covid
crop
deal
debut
develops
draw
drug
Language
unset
Current search:
sciences
×
cancer
×
" texas blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M